AstraZeneca says board will review Pfizer offer

LONDON Fri May 2, 2014 2:42am EDT

LONDON May 2 (Reuters) - AstraZeneca's board will be reviewing a sweetened takeover offer from Pfizer but the company has no further comment at this stage, a spokeswoman for the British drugmaker said on Friday.

Earlier the U.S. drugmaker revealed it had raised its offer for the British group to 63 billion pounds ($106 billion). (Reporting by Ben Hirschler; editing by Kate Holton)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.